Published 12 days ago

Lecanemab Extension Study for AD Offers Mixed Results

Summary by mdedge.com

The lecanemab open-label extension trial for AD showed no new safety signals, but the placebo roll-over group failed to show the gains seen in the experimental arm.

0 Articles

All

Left

Center

Right

mdedge.com

Lecanemab Extension Study for AD Offers Mixed Results

The lecanemab open-label extension trial for AD showed no new safety signals, but the placebo roll-over group failed to show the gains seen in the experimental arm.

12 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated12 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Lecanemab Extension Study for AD Offers Mixed Results

0 Articles

0 Articles

Lecanemab Extension Study for AD Offers Mixed Results

Lecanemab Extension Study for AD Offers Mixed Results

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics